本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vir Biotechnology, Inc.

5.69
+0.05500.98%
成交量:43.48万
成交额:244.41万
市值:7.91亿
市盈率:-1.57
高:5.70
开:5.56
低:5.48
收:5.63
52周最高:14.45
52周最低:4.16
股本:1.39亿
流通股本:9,455.46万
量比:0.56
换手率:0.46%
股息:- -
股息率:- -
每股收益(TTM):-3.6228
每股收益(LYR):-3.8310
净资产收益率:-49.06%
总资产收益率:-25.97%
市净率:0.99
市盈率(LYR):-1.48

数据加载中...

2025/05/07

重要事件披露

Form 8-K - Current report
2025/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/30

重要事件披露

Form 8-K - Current report
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]